A citation-based method for searching scientific literature

S E Clark, J Warwick, R Carpenter, R L Bowen, S W Duffy, J L Jones. Br J Cancer 2011
Times Cited: 84







List of co-cited articles
575 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.
Rulla M Tamimi, Heather J Baer, Jonathan Marotti, Mark Galan, Laurie Galaburda, Yineng Fu, Anne C Deitz, James L Connolly, Stuart J Schnitt, Graham A Colditz,[...]. Breast Cancer Res 2008
218
26

Identification of a basal-like subtype of breast ductal carcinoma in situ.
Chad A Livasy, Charles M Perou, Gamze Karaca, David W Cowan, Diane Maia, Susan Jackson, Chiu-Kit Tse, Sarah Nyante, Robert C Millikan. Hum Pathol 2007
155
25


Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
20

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
231
20

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
318
19

Classification of ductal carcinoma in situ by gene expression profiling.
Juliane Hannemann, Arno Velds, Johannes B G Halfwerk, Bas Kreike, Johannes L Peterse, Marc J van de Vijver. Breast Cancer Res 2006
117
17



Gene expression profiles of human breast cancer progression.
Xiao-Jun Ma, Ranelle Salunga, J Todd Tuggle, Justin Gaudet, Edward Enright, Philip McQuary, Terry Payette, Maria Pistone, Kimberly Stecker, Brian M Zhang,[...]. Proc Natl Acad Sci U S A 2003
624
16

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
16

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
444
15

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
372
15


Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.
Anne Vincent-Salomon, Carlo Lucchesi, Nadège Gruel, Virginie Raynal, Gaëlle Pierron, Rémi Goudefroye, Fabien Reyal, François Radvanyi, Rémy Salmon, Jean-Paul Thiery,[...]. Clin Cancer Res 2008
111
15

Immunohistochemical categorisation of ductal carcinoma in situ of the breast.
P Meijnen, J L Peterse, N Antonini, E J Th Rutgers, M J van de Vijver. Br J Cancer 2008
76
17

Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.
Aslaug Aamodt Muggerud, Michael Hallett, Hilde Johnsen, Kristine Kleivi, Wenjing Zhou, Simin Tahmasebpoor, Rose-Marie Amini, Johan Botling, Anne-Lise Børresen-Dale, Therese Sørlie,[...]. Mol Oncol 2010
80
16

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
323
14

HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer.
Robert E Roses, E Carter Paulson, Anupama Sharma, Jeanne E Schueller, Harvey Nisenbaum, Susan Weinstein, Kevin R Fox, Paul J Zhang, Brian J Czerniecki. Cancer Epidemiol Biomarkers Prev 2009
93
14

Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
H Buerger, F Otterbach, R Simon, C Poremba, R Diallo, T Decker, L Riethdorf, C Brinkschmidt, B Dockhorn-Dworniczak, W Boecker. J Pathol 1999
245
14

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
173
14

Regulation of in situ to invasive breast carcinoma transition.
Min Hu, Jun Yao, Danielle K Carroll, Stanislawa Weremowicz, Haiyan Chen, Daniel Carrasco, Andrea Richardson, Shelia Violette, Tatiana Nikolskaya, Yuri Nikolsky,[...]. Cancer Cell 2008
363
13

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
Nina Bijker, Philip Meijnen, Johannes L Peterse, Jan Bogaerts, Irène Van Hoorebeeck, Jean-Pierre Julien, Massimiliano Gennaro, Philippe Rouanet, Antoine Avril, Ian S Fentiman,[...]. J Clin Oncol 2006
436
13

Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast.
E Provenzano, J L Hopper, G G Giles, G Marr, D J Venter, J E Armes. Eur J Cancer 2003
89
11

Repeated observation of breast tumor subtypes in independent gene expression data sets.
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Andrew Nobel, Shibing Deng, Hilde Johnsen, Robert Pesich, Stephanie Geisler,[...]. Proc Natl Acad Sci U S A 2003
11

Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
D Craig Allred, Yun Wu, Sufeng Mao, Iris D Nagtegaal, Sangjun Lee, Charles M Perou, Syed K Mohsin, Peter O'Connell, Anna Tsimelzon, Dan Medina. Clin Cancer Res 2008
202
11



HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.
E Rakovitch, S Nofech-Mozes, W Hanna, S Narod, D Thiruchelvam, R Saskin, J Spayne, C Taylor, L Paszat. Br J Cancer 2012
88
11


Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study.
Wenjing Zhou, Karin Jirström, Rose-Marie Amini, Marie-Louise Fjällskog, Thomas Sollie, Henrik Lindman, Therese Sørlie, Carl Blomqvist, Fredrik Wärnberg. BMC Cancer 2013
41
24

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.
D C Allred, G M Clark, R Molina, A K Tandon, S J Schnitt, K W Gilchrist, C K Osborne, D C Tormey, W L McGuire. Hum Pathol 1992
355
10


Prognostic classification of breast ductal carcinoma-in-situ.
M J Silverstein, D N Poller, J R Waisman, W J Colburn, A Barth, E D Gierson, B Lewinsky, P Gamagami, D J Slamon. Lancet 1995
505
10

Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.
David J Dabbs, Mamatha Chivukula, Gloria Carter, Rohit Bhargava. Mod Pathol 2006
93
10

Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
188
10

Progression from ductal carcinoma in situ to invasive breast cancer: revisited.
Catherine F Cowell, Britta Weigelt, Rita A Sakr, Charlotte K Y Ng, James Hicks, Tari A King, Jorge S Reis-Filho. Mol Oncol 2013
132
10

Gene expression profiling of the tumor microenvironment during breast cancer progression.
Xiao-Jun Ma, Sonika Dahiya, Elizabeth Richardson, Mark Erlander, Dennis C Sgroi. Breast Cancer Res 2009
447
9

Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Nadia P Castro, Cynthia A B T Osório, César Torres, Elen P Bastos, Mário Mourão-Neto, Fernando A Soares, Helena P Brentani, Dirce M Carraro. Breast Cancer Res 2008
95
9

Molecular characterization of the tumor microenvironment in breast cancer.
Minna Allinen, Rameen Beroukhim, Li Cai, Cameron Brennan, Jaana Lahti-Domenici, Haiyan Huang, Dale Porter, Min Hu, Lynda Chin, Andrea Richardson,[...]. Cancer Cell 2004
933
9

Molecular markers in ductal carcinoma in situ of the breast.
Dale Porter, Jaana Lahti-Domenici, Aparna Keshaviah, Young Kyung Bae, Pedram Argani, Jeffrey Marks, Andrea Richardson, Amiel Cooper, Robert Strausberg, Gregory J Riggins,[...]. Mol Cancer Res 2003
208
9

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.
P O'Connell, V Pekkel, S A Fuqua, C K Osborne, G M Clark, D C Allred. J Natl Cancer Inst 1998
259
9

Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes.
H Buerger, F Otterbach, R Simon, K L Schäfer, C Poremba, R Diallo, C Brinkschmidt, B Dockhorn-Dworniczak, W Boecker. J Pathol 1999
182
9

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.
N Bijker, J L Peterse, L Duchateau, J P Julien, I S Fentiman, C Duval, S Di Palma, J Simony-Lafontaine, I de Mascarel, M J van de Vijver. J Clin Oncol 2001
351
9

Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group.
Lorie L Hughes, Molin Wang, David L Page, Robert Gray, Lawrence J Solin, Nancy E Davidson, Mary Ann Lowen, James N Ingle, Abram Recht, William C Wood. J Clin Oncol 2009
212
9

Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study.
Wenjing Zhou, Karin Jirström, Christine Johansson, Rose-Marie Amini, Carl Blomqvist, Olorunsola Agbaje, Fredrik Wärnberg. BMC Cancer 2010
30
26

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
D Craig Allred, Stewart J Anderson, Soonmyung Paik, D Lawrence Wickerham, Iris D Nagtegaal, Sandra M Swain, Elefetherios P Mamounas, Thomas B Julian, Charles E Geyer, Joseph P Costantino,[...]. J Clin Oncol 2012
195
9

Intraductal carcinoma of the breast: follow-up after biopsy only.
D L Page, W D Dupont, L W Rogers, M Landenberger. Cancer 1982
477
9

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
J P Julien, N Bijker, I S Fentiman, J L Peterse, V Delledonne, P Rouanet, A Avril, R Sylvester, F Mignolet, H Bartelink,[...]. Lancet 2000
403
9

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.